Redmond Lab
Welcome to the Redmond Vascular Biology Lab
Cardiovascular disease
Atherosclerosis, a hardening and narrowing of arterial blood vessels, is the most common form of cardiovascular disease and a leading cause of death and disability worldwide for both women and men. In the United States alone heart attacks and stroke caused by atherosclerosis result in approximately 800,000 deaths annually (1 of every 3 deaths) with an associated economic cost of $351 billion in 2020. This despite current treatments that include preventative medical therapies and lifestyle changes, in addition to revascularization and stenting of obstructed arteries to reduce ischemia and improve quality of life. Our lab uses state-of-the-art in vitro and in vivo techniques to gain insight into the cell populations (smooth muscle, endothelial, stem cell), signaling mechanisms, and molecular processes mediating atherosclerotic plaque development and progression.
Alcohol and cardiovascular disease
Alcohol consumption is a modifiable behaviour of considerable interest in relation to cardiovascular health. Drinking may have either positive or negative effects, depending not only on the total amount consumed but also the pattern of consumption. Population studies reveal that chronic alcohol abuse and binge drinking are associated with increased cardiovascular-related morbidity and mortality. On the other hand, compared with abstinence, regular alcohol consumption at low to moderate levels is associated with reduced death from myocardial infarction and ischemic stroke. Currently lacking, however, is an in-depth knowledge of how alcohol impacts the various cell types present in arteries to ultimately dictate vessel disease development and progression. Elucidating, at a basic science level, the cell and molecular mechanisms mediating the effects of alcohol on cardiovascular health and disease, particularly the apparent beneficial effects of low to moderate consumption, would be of great significance and is a major focus of our lab. Our goal is to increase understanding of precisely how alcohol impacts vessel health while yielding new information enabling the design of innovative targeted therapies for cardiovascular disease in addition to informing, on a scientific basis, public health guidelines re alcohol consumption and cardiovascular health.
Eileen M. Redmond, Ph.D.
Principal Investigator
Publications
View All Publications- Alcohol and vascular endothelial function: Biphasic effect highlights the importance of dose.; Alcohol, clinical & experimental research; Vol 47(8), pp. 1467-1477. 2023 Jul 10.
- Caveolin-1 inhibition mediates the opposing effects of alcohol on γ-secretase activity in arterial endothelial and smooth muscle cells.; Physiological reports; Vol 11(1), pp. e15544. 2023 Jan.
- Exosomal Composition, Biogenesis and Profiling Using Point-of-Care Diagnostics-Implications for Cardiovascular Disease.; Frontiers in cell and developmental biology; Vol 10, pp. 853451. 2022 Jun 01.
- Moderate dose alcohol protects against serum amyloid protein A1-induced endothelial dysfunction via both notch-dependent and notch-independent pathways.; Alcoholism, clinical and experimental research. 2021 Sep 29.
- Disease-Relevant Single Cell Photonic Signatures Identify S100β Stem Cells and their Myogenic Progeny in Vascular Lesions.; Stem cell reviews and reports. 2021 Mar 17.
- The calcium binding protein S100β marks hedgehog-responsive resident vascular stem cells within vascular lesions.; NPJ Regenerative medicine; Vol 6(1). 2021 Mar 01.
Contact Us
Redmond Lab
601 Elmwood Ave
Rochester, NY 14642